Development of a new anti-inflammatory pharmacological approach for the treatment of septic shock
-
Home
- Ricerca
- Progetti
- Development of a new anti-inflammatory pharmacological approach for the treatment of septic shock
- Data inizio
- 1 settembre 2006
- Durata (mesi)
- 12
- Responsabili (o referenti locali)
-
Laudanna Carlo
- Parole chiave
- Septic shock, Leukocyte recruitment, Cytokine, Oxidative stress, Signal transduction
- Identification and characterization of novel V-ATPases inhibitors able to interfere adhesive and pro-inflammatory activities of leukocytes in in vitro assays.
- Effect of V-ATPase inhibitors on rapid integrin activation and dependent adhesion
- Effect of V-APTase inhibitors on chemotaxis
- Effect of V-APTase inhibitors on generation of oxygen free-radicals (oxidative stress)
- Effect of V-ATPase inhibitors on pro-inflammatory cytokine production
- Pharmacological characterization of the capability of V-ATPases inhibitors onset and/or to reduce the severity of septic shock in animal models.
- Effect of V-ATP-ase inhibitors on onset and progression of septic shock
- Identification of compound-related activity, best dosage and toxic effect
Enti finanziatori:
-
-
Finanziamento: assegnato e gestito dal Dipartimento
